(Q43716352)

26 November 2017

title

Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission (English)

1 reference

26 November 2017

1 reference

3

1 reference

26 November 2017

6

M Simren

1 reference

26 November 2017

B Jonefjäll

1

1 reference

26 November 2017

H Strid

series ordinal

2

1 reference

26 November 2017

J Svedlund

series ordinal

4

1 reference

26 November 2017

A Bergstedt

series ordinal

5

1 reference

26 November 2017

publication date

4 June 2013

1 reference

Neurogastroenterology and Motility

26 November 2017

published in

1 reference

26 November 2017

volume

25

1 reference

26 November 2017

issue

9

1 reference

26 November 2017

page(s)

756-e578

1 reference

Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors

26 November 2017

cites work

1 reference

Symptoms of irritable bowel syndrome in ulcerative colitis in remission

21 January 2018

1 reference

Ulcerative colitis and irritable bowel syndrome: relationships with quality of life

21 January 2018

1 reference

Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

21 January 2018

1 reference

IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior

21 January 2018

1 reference

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes

21 January 2018

1 reference

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

21 January 2018

1 reference

Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy

21 January 2018

1 reference

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Functional bowel disorders and functional abdominal pain

21 January 2018

1 reference

The hospital anxiety and depression scale

21 January 2018

1 reference

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

The immune system in irritable bowel syndrome

21 January 2018

1 reference

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia

21 January 2018

1 reference

Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis

21 January 2018

1 reference

New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.

21 January 2018

1 reference

Irritable bowel syndrome in the general population

21 January 2018

1 reference

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/NMO.12163

1 reference

26 November 2017

1 reference